Two barriers prevent adenovirus-based vectors from having wide applica
tion One is the difficulty of making new adenoviruses, and the second
is the strong immunological reaction to viral proteins. Here He descri
be uses of Cre-lox recombination to overcome these problems. First, we
demonstrate a simple method for constructing E1-substituted adenoviru
ses. Second, we demonstrate a method to construct adenovirus vectors c
arrying recombinant genes in place of all of the viral genes, so-calle
d gutless adenovirus vectors. The pivotal feature in each method is th
e use of a negatively selected adenovirus named Psi 5. We engineered a
cis-acting selection into Psi 5 by flanking its packaging site with l
oxP sites. When Psi 5 was grown in cells making a high level of Cre re
combinase, the packaging site was deleted by recombination and the yie
ld of Psi 5 was reduced to 5% of the wild-type level. To make a new E1
-substituted virus, we used Psi 5 as a donor virus and recombined it w
ith a shuttle vector via a loxP site. The resulting recombinant virus
has a single loxP site next to the packaging site and therefore outgro
ws Psi 5 in the presence of Cre recombinase. To make a gutless virus,
we used Psi 5 as a helper virus. The only viral sequences included in
the gutless vector are those needed in cis for its replication and pac
kaging. We found that a loxP site next to the packaging site of the gu
tless virus was necessary to neutralize homologous recombination betwe
en Psi 5 and the gutless viruses within their packaging domains.